Vandria

We are developing first-in-class small molecules against a novel target to improve mitochondrial function and reduce chronic inflammation to treat age-related diseases.

Health and bio

Latest funding

$30.7M Series A · August 21, 2024

Source: fundraisingfox.com

All 2 rounds ↓

Website: vandria.com.

LinkedIn: vandria-sa.

Category: Health and bio.

Stage: Series A.

Last round: Aug 21, 2024 · 813 days ago.

On Recent Funding since: Nov 8, 2026.

Signals

Website registeredFeb 10, 2018 (8 years old)

Funding rounds

August 21, 2024
Series A · $30.7M
Source: fundraisingfox.com
December 14, 2023
Series A · amount undisclosed
Source: fundraisingfox.com
February 10, 2018
Website created

Companies like Vandria

MModel Medicines$4.1M · Nov 2021
LLifeCyte Innovations$1M Seed · Aug 2026
RRoca TherapeuticsSeed · Sep 2022
DDiadem Biotherapeutics
RRougeTx$58M Series A · Oct 2026
PProtego$130M Series B+ · Dec 2025

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/vandria (get a free API key).